TY - JOUR
T1 - Endoscopic ultrasound-guided biliary drainage in benign biliary pathology with normal foregut anatomy
T2 - a multicenter study
AU - Bill, Jason G.
AU - Ryou, Marvin
AU - Hathorn, Kelly E.
AU - Cortes, Pedro
AU - Maple, John T.
AU - Al-Shahrani, Abdullah
AU - Lang, Gabriel
AU - Mullady, Daniel K.
AU - Das, Koushik
AU - Cosgrove, Natalie
AU - Salameh, Habeeb
AU - Kumta, Nikhil A.
AU - DiMaio, Christopher J.
AU - Zia, Hassaan
AU - Orr, Jordan
AU - Yachimski, Patrick
AU - Kushnir, Vladimir M.
N1 - Funding Information:
Christopher DiMaio performs teaching and consulting for Boston Scientific, Medtronic, AbbVie, Daniel Mullady performs consulting for Boston Scientific and Cook is on the Speaker’s Bureau for AbbVie, Patrick Yachimski is a consultant for Boston Scientific and has received grant funding from the American Gastroenterological Association for work unrelated to this project. Jason G. Bill, Marvin Ryou, Kelly E. Hathorn, Pedro Cortes, John T. Maple, Abdullah Al-Shahrani, Gabriel Lang, Koushik Das, Natalie Cosgrove, Habeeb Salameh, Nikhil A. Kumta, Hassaan Zia, Jordan Orr, Vladimir M. Kushnir have no conflicts of interest or financial ties to disclose.
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2022/2
Y1 - 2022/2
N2 - Background and aims: Biliary drainage using endoscopic ultrasound (EUS-BD) has been developed as a novel technique to obtain biliary access and drainage when ERCP fails. Numerous studies have demonstrated its safety and efficacy specifically pertaining to those with malignant distal biliary obstruction or altered foregut anatomy. The aim of this study is to evaluate the safety and efficacy of EUS-BD in benign indications in patients with normal foregut anatomy. Methods: We performed a retrospective comparative study from 5 academic medical centers (2008–2018) involving patients with benign biliary obstruction and native foregut anatomy who had an initial failed ERCP with subsequent attempt at biliary decompression via EUS-BD or by repeating ERCP. Results: 36 patients (mean age 61.6 ± 2.2, 38.9% female) who underwent attempted EUS-BD following initial failed ERCP were compared to 50 patients (mean age 62.7 ± 2.3, 73.5% female) who underwent repeat ERCP following an initial failed cannulation. EUS-BD was technically successful in 28 (77.8%) patients with rendezvous being the most common approach (86.1%). A higher level of pre-procedural bilirubin was found to be associated with technical success of EUS-BD (3.65 ± 0.63 versus 1.1 ± 0.4, p value 0.04). Success of repeat ERCP following failed cannulation was 86%. Adverse events were significantly more frequent in the EUS-BD cohort when compared to the repeat ERCP (10 (27.8%) versus 4 (8.0%), p = 0.02, OR 4.32. Conclusions: EUS-BD remains a viable therapeutic option in the setting of benign biliary disease, with success rates of 77.8%. Adverse events were significantly more common with EUS-BD vs. repeat ERCP, emphasizing the need to perform in expert centers with appropriate multidisciplinary support and to strongly consider the urgency of biliary decompression before considering same session EUS-BD after failed initial biliary access.
AB - Background and aims: Biliary drainage using endoscopic ultrasound (EUS-BD) has been developed as a novel technique to obtain biliary access and drainage when ERCP fails. Numerous studies have demonstrated its safety and efficacy specifically pertaining to those with malignant distal biliary obstruction or altered foregut anatomy. The aim of this study is to evaluate the safety and efficacy of EUS-BD in benign indications in patients with normal foregut anatomy. Methods: We performed a retrospective comparative study from 5 academic medical centers (2008–2018) involving patients with benign biliary obstruction and native foregut anatomy who had an initial failed ERCP with subsequent attempt at biliary decompression via EUS-BD or by repeating ERCP. Results: 36 patients (mean age 61.6 ± 2.2, 38.9% female) who underwent attempted EUS-BD following initial failed ERCP were compared to 50 patients (mean age 62.7 ± 2.3, 73.5% female) who underwent repeat ERCP following an initial failed cannulation. EUS-BD was technically successful in 28 (77.8%) patients with rendezvous being the most common approach (86.1%). A higher level of pre-procedural bilirubin was found to be associated with technical success of EUS-BD (3.65 ± 0.63 versus 1.1 ± 0.4, p value 0.04). Success of repeat ERCP following failed cannulation was 86%. Adverse events were significantly more frequent in the EUS-BD cohort when compared to the repeat ERCP (10 (27.8%) versus 4 (8.0%), p = 0.02, OR 4.32. Conclusions: EUS-BD remains a viable therapeutic option in the setting of benign biliary disease, with success rates of 77.8%. Adverse events were significantly more common with EUS-BD vs. repeat ERCP, emphasizing the need to perform in expert centers with appropriate multidisciplinary support and to strongly consider the urgency of biliary decompression before considering same session EUS-BD after failed initial biliary access.
KW - Biliary obstruction
KW - EUS guided biliary drainage
KW - Failed ERCP
UR - http://www.scopus.com/inward/record.url?scp=85102339437&partnerID=8YFLogxK
U2 - 10.1007/s00464-021-08418-w
DO - 10.1007/s00464-021-08418-w
M3 - Article
C2 - 33712939
AN - SCOPUS:85102339437
SN - 0930-2794
VL - 36
SP - 1362
EP - 1368
JO - Surgical Endoscopy and Other Interventional Techniques
JF - Surgical Endoscopy and Other Interventional Techniques
IS - 2
ER -